Celyad Oncology SA

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: BE0974260896
EUR
0.30
0.02 (5.65%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCelyad Oncology SA VS Pharmaceuticals & Biotechnology
 
1D
5.65%
-0.8%
1W
1.36%
3.24%
1M
-4.78%
4.89%
YTD
75.88%
10.34%
1Y
-31.58%
24.74%
3Y
-43.16%
53.44%
5Y
-93.46%
37.96%
10Y
-99.35%
59.38%
  • Stock Absolute Returns
  • Belgium BEL 20Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-22.34%
0%
-22.34%
6 Months
51.01%
0%
51.01%
1 Year
-31.58%
0%
-31.58%
2 Years
-0.5%
0%
-0.5%
3 Years
-43.16%
0%
-43.16%
4 Years
-84.67%
0%
-84.67%
5 Years
-93.46%
0%
-93.46%

Celyad Oncology SA for the last several years.

stock-summaryRisk Adjusted Returns v/s Belgium BEL 20
Risk Adjusted Returns v/s stock-summary